Compound ID | 1802
Pei
Class: Pseudomonas elastase inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Antivirulence approach used against Pseudomonas aeruginosa. Inhibitor of Elastase (LasB) |
| Combined with other compounds: | Yes |
| Description: | Synthetic compound. Developed as inhaled treatment of P. aeruginosa infections in chronic respiratory disease. |
| Institute where first reported: | Antabio |
| Year first mentioned: | 2021 |
| Highest developmental phase: | Preclinical |
| Development status: | Active (as of 2022) |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.